South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 1.48 trillion. The enterprise value is 2.38 trillion.
| Market Cap | 1.48T |
| Enterprise Value | 2.38T |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 25.65% |
| Float | 5.38M |
Valuation Ratios
The trailing PE ratio is 7.58 and the forward PE ratio is 9.00.
| PE Ratio | 7.58 |
| Forward PE | 9.00 |
| PS Ratio | 0.91 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 2.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.14 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.16 |
| EV / Sales | 1.45 |
| EV / EBITDA | 8.26 |
| EV / EBIT | 10.80 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.78.
| Current Ratio | 0.89 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 3.60 |
| Debt / FCF | -8.90 |
| Interest Coverage | 12.93 |
Financial Efficiency
Return on equity (ROE) is 16.64% and return on invested capital (ROIC) is 9.78%.
| Return on Equity (ROE) | 16.64% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 9.78% |
| Return on Capital Employed (ROCE) | 11.28% |
| Weighted Average Cost of Capital (WACC) | 3.25% |
| Revenue Per Employee | 994.66M |
| Profits Per Employee | 118.90M |
| Employee Count | 1,644 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.54 |
Taxes
In the past 12 months, KRX:069620 has paid 1.12 billion in taxes.
| Income Tax | 1.12B |
| Effective Tax Rate | 0.62% |
Stock Price Statistics
The stock price has decreased by -8.43% in the last 52 weeks. The beta is 0.01, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -8.43% |
| 50-Day Moving Average | 122,952.00 |
| 200-Day Moving Average | 150,586.00 |
| Relative Strength Index (RSI) | 51.36 |
| Average Volume (20 Days) | 34,867 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.64 trillion and earned 195.47 billion in profits. Earnings per share was 16,988.81.
| Revenue | 1.64T |
| Gross Profit | 854.64B |
| Operating Income | 189.23B |
| Pretax Income | 179.56B |
| Net Income | 195.47B |
| EBITDA | 256.82B |
| EBIT | 189.23B |
| Earnings Per Share (EPS) | 16,988.81 |
Balance Sheet
The company has 158.42 billion in cash and 925.02 billion in debt, with a net cash position of -766.60 billion or -66,624.49 per share.
| Cash & Cash Equivalents | 158.42B |
| Total Debt | 925.02B |
| Net Cash | -766.60B |
| Net Cash Per Share | -66,624.49 |
| Equity (Book Value) | 1.19T |
| Book Value Per Share | 92,465.40 |
| Working Capital | -98.82B |
Cash Flow
In the last 12 months, operating cash flow was 162.15 billion and capital expenditures -266.09 billion, giving a free cash flow of -103.95 billion.
| Operating Cash Flow | 162.15B |
| Capital Expenditures | -266.09B |
| Depreciation & Amortization | 67.59B |
| Net Borrowing | 181.85B |
| Free Cash Flow | -103.95B |
| FCF Per Share | -9,034.16 |
Margins
Gross margin is 52.26%, with operating and profit margins of 11.57% and 11.95%.
| Gross Margin | 52.26% |
| Operating Margin | 11.57% |
| Pretax Margin | 10.98% |
| Profit Margin | 11.95% |
| EBITDA Margin | 15.71% |
| EBIT Margin | 11.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.63% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.52% |
| Earnings Yield | 13.19% |
| FCF Yield | -7.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KRX:069620 is 204,444.44, which is 58.73% higher than the current price. The consensus rating is "Buy".
| Price Target | 204,444.44 |
| Price Target Difference | 58.73% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 1.56% |
| EPS Growth Forecast (3Y) | 2.93% |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.11 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 5 |